Eris Lifesciences Limited on Tuesday posted a standalone net profit of ₹87 crore for the first quarter ended June 2020, as against ₹82 crore recorded in the corresponding quarter a year ago, indicating 6 per cent year-on-year rise.
Its revenues from operations stood at ₹261 crore, as against ₹262 crore.
On consolidated basis, its net profit stood at ₹89 crore, which is about 6 per cent higher than ₹84 crore it recorded in the same quarter last year. The consolidated revenues from operations stood at ₹293 crore for the quarter as against ₹277 crore last year for same quarter.
The board of directors has declared interim dividend of ₹5.50 (at the rate of 550 per cent) on each fully paid-up equity share of ₹1 for the financial year 2020-21.
Company shares ended at ₹510 on Tuesday, down by nearly 6 per cent from previous close on the Bombay Stock Exchange.